“It is a very serious disease with serious complications from which patients die relatively young,” says hematologist Linet Njue, senior physician at Inselspital Bern. According to the doctor, around 100 patients with the disease are being treated in large university hospitals in Switzerland, but the exact number is not recorded. It is one of the most common hereditary diseases worldwide.
The disease is caused by a gene that carries the blueprint for the red blood pigment haemoglobin. A gene mutation crystallizes the hemoglobin, causing the normally round red blood cells to deform into sickles. These, in turn, clog the bloodstream.
Now, the UK Medicines Agency has given the green light for a new gene therapy for sickle cell anaemia patients aged 12 and over. It is called Exacel (brand name “Casgevy”) and was developed by the companies Vertex Pharmaceuticals and CRISPR Therapeutics, the latter based in Zug.
It is the first ever approved treatment based on the CRISPR/Cas9 gene scissors. This is the technology that can precisely cut through and modify the genetic material and for the discovery of which the Nobel Prize in Chemistry was awarded in 2020.
No need for a foreign donor anymore
Victoria Gray, now 37, was the first person to be treated with the therapy in 2019. Thanks to the new “supercells”, her life has changed completely, she recently said. She now lives free of pain, can go back to work and take care of her four children.
Exacel has now been tested on around forty sickle cell anemia patients. As Vertex Pharmaceuticals and CRISPR Therapeutics have announced, additional clinical trials with children between the ages of 2 and 11 are now to begin. An application for approval for the therapy has not yet been received from the companies in Switzerland, as Swissmedic confirmed on request.
How Exacel Therapy WorksExacel does not target the disease-causing and mutated HBB gene, which causes the sickle-shaped blood cells. Rather, the therapy is dedicated to the gene called BCL11A. This gene is activated at birth and thus inhibits the formation of haemoglobin, which is actually only produced in the fetus. Exacel then cuts BCL11A apart, which deactivates the gene again and resumes prenatal hemoglobin production. This provides additional hemoglobin that is not malformed. The symptoms of the disease disappear. (sny)
Jacob Corn is Professor of Genome Biology at ETH Zurich and has been working on CRISPR treatments for years, including for sickle cell disease. “The whole CRISPR community is in a frenzy. The Exacel successes are impressive,” he says.
Nevertheless, it is crucial to accompany the treated patients over a long period of time, the regulatory authorities require at least 15 years. This is the only way to rule out long-term side effects, such as an increased risk of blood cancer – a concern that worries some scientists. However, Corn emphasizes: “At the moment, things are looking really good.”
According to the ETH professor, the CRISPR gene scissors offer a gateway to a new world of medicine. He draws a comparison:
It’s the same with hereditary diseases so far: You can make a genetic diagnosis to suffering patients, but you can’t offer them a therapy – that’s changing now.
There are more than 7000,1 diseases that are based on a single gene mutation, such as sickle cell anemia, and dozens of therapies are already in the pipeline, for example against the metabolic disease called familial hypercholesterolemia, which affects about 200 in <> people in Switzerland.
Due to the disease, a dangerous amount of cholesterol always remains in the blood. This greatly increases the risk of a heart attack or stroke. Studies with the CRISPR therapy from the biotech company Verve Therapeutics have so far been promising, even suggesting that “the world’s biggest killer” can soon be stopped, according to the headline of the US magazine “MIT Technology Review”.
Targeting multiple genes is much more difficult
Other diseases in the focus of the genetic engineers are cystic fibrosis, Duchenne muscular dystrophy or progeria, in which affected children age as if in fast motion. In addition to these single-mutation diseases, there are countless other diseases that are based on a combination of several gene mutations and environmental factors: Alzheimer’s, arthritis, many cancers, diabetes, autism spectrum disorders are just a few examples.
Another hurdle of future CRISPR therapies is those diseases that affect organs that are difficult to reach. In sickle cell anemia, it is comparatively easy to extract the blood cells from the body, manipulate them and return them. “In cystic fibrosis, on the other hand, where the lungs are damaged, it is a much more difficult procedure to get the genetic medicine to the right place,” says Corn.
The high cost could limit availability
Geneticists are very worried about the horrendous costs, which are estimated to run into the millions for a single CRISPR treatment. It is questionable whether poorer countries can afford such therapies. Even rich countries get into trouble when a large number of patients suddenly want to be treated.
One dilemma, according to Jacob Corn, is that the safety requirements imposed by the health authorities are enormously high – and therefore costly. “That’s good, because it must be guaranteed that the therapies do no more harm than good.” The hope is that after the first approvals, the multitude of safety and efficacy tests will no longer have to be carried out every single time. “If the safety of CRISPR technology is proven on its own, then hopefully it would be legitimate to accelerate the testing and approval of therapies for other diseases,” says Corn.
Another approach: Instead of isolating the cells for the gene changes, treating them and then injecting them back into the body, researchers are tinkering with a gene injection: “The idea is that the genome editing process is injected into the body, so to speak, where it finds the right place and exerts its effect.” This would not only make treatment cheaper, but also more accessible, for example in regions of Africa where there are few health facilities. No tests have yet been carried out in humans, only in animals.
But Jacob Corn is confident: “A large number of research groups around the world are involved in CRISPR. How quickly things can sometimes happen when many bright minds are working on a problem at the same time was seen with the Corona vaccination.” (aargauerzeitung.ch)

News
Studies detail high rates of long COVID among healthcare, dental workers
Researchers have estimated approximately 8% of Americas have ever experienced long COVID, or lasting symptoms, following an acute COVID-19 infection. Now two recent international studies suggest that the percentage is much higher among healthcare workers [...]
Melting Arctic Ice May Unleash Ancient Deadly Diseases, Scientists Warn
Melting Arctic ice increases human and animal interactions, raising the risk of infectious disease spread. Researchers urge early intervention and surveillance. Climate change is opening new pathways for the spread of infectious diseases such [...]
Scientists May Have Found a Secret Weapon To Stop Pancreatic Cancer Before It Starts
Researchers at Cold Spring Harbor Laboratory have found that blocking the FGFR2 and EGFR genes can stop early-stage pancreatic cancer from progressing, offering a promising path toward prevention. Pancreatic cancer is expected to become [...]
Breakthrough Drug Restores Vision: Researchers Successfully Reverse Retinal Damage
Blocking the PROX1 protein allowed KAIST researchers to regenerate damaged retinas and restore vision in mice. Vision is one of the most important human senses, yet more than 300 million people around the world are at [...]
Differentiating cancerous and healthy cells through motion analysis
Researchers from Tokyo Metropolitan University have found that the motion of unlabeled cells can be used to tell whether they are cancerous or healthy. They observed malignant fibrosarcoma cells and [...]
This Tiny Cellular Gate Could Be the Key to Curing Cancer – And Regrowing Hair
After more than five decades of mystery, scientists have finally unveiled the detailed structure and function of a long-theorized molecular machine in our mitochondria — the mitochondrial pyruvate carrier. This microscopic gatekeeper controls how [...]
Unlocking Vision’s Secrets: Researchers Reveal 3D Structure of Key Eye Protein
Researchers have uncovered the 3D structure of RBP3, a key protein in vision, revealing how it transports retinoids and fatty acids and how its dysfunction may lead to retinal diseases. Proteins play a critical [...]
5 Key Facts About Nanoplastics and How They Affect the Human Body
Nanoplastics are typically defined as plastic particles smaller than 1000 nanometers. These particles are increasingly being detected in human tissues: they can bypass biological barriers, accumulate in organs, and may influence health in ways [...]
Measles Is Back: Doctors Warn of Dangerous Surge Across the U.S.
Parents are encouraged to contact their pediatrician if their child has been exposed to measles or is showing symptoms. Pediatric infectious disease experts are emphasizing the critical importance of measles vaccination, as the highly [...]
AI at the Speed of Light: How Silicon Photonics Are Reinventing Hardware
A cutting-edge AI acceleration platform powered by light rather than electricity could revolutionize how AI is trained and deployed. Using photonic integrated circuits made from advanced III-V semiconductors, researchers have developed a system that vastly [...]
A Grain of Brain, 523 Million Synapses, Most Complicated Neuroscience Experiment Ever Attempted
A team of over 150 scientists has achieved what once seemed impossible: a complete wiring and activity map of a tiny section of a mammalian brain. This feat, part of the MICrONS Project, rivals [...]
The Secret “Radar” Bacteria Use To Outsmart Their Enemies
A chemical radar allows bacteria to sense and eliminate predators. Investigating how microorganisms communicate deepens our understanding of the complex ecological interactions that shape our environment is an area of key focus for the [...]
Psychologists explore ethical issues associated with human-AI relationships
It's becoming increasingly commonplace for people to develop intimate, long-term relationships with artificial intelligence (AI) technologies. At their extreme, people have "married" their AI companions in non-legally binding ceremonies, and at least two people [...]
When You Lose Weight, Where Does It Actually Go?
Most health professionals lack a clear understanding of how body fat is lost, often subscribing to misconceptions like fat converting to energy or muscle. The truth is, fat is actually broken down into carbon [...]
How Everyday Plastics Quietly Turn Into DNA-Damaging Nanoparticles
The same unique structure that makes plastic so versatile also makes it susceptible to breaking down into harmful micro- and nanoscale particles. The world is saturated with trillions of microscopic and nanoscopic plastic particles, some smaller [...]
AI Outperforms Physicians in Real-World Urgent Care Decisions, Study Finds
The study, conducted at the virtual urgent care clinic Cedars-Sinai Connect in LA, compared recommendations given in about 500 visits of adult patients with relatively common symptoms – respiratory, urinary, eye, vaginal and dental. [...]